When we blocked NF-κB signaling using p62 inhibition in ovarian cancer cells treated with cisplatin, the expressions of proliferation-related genes such as CCL2, IL6, TGFb and CSF3 genes were significantly suppressed and DNA synthesis was reduced [31]. Here, NFKB1 is linked to ovarian carcinoma.